Preoperatory treatment with Triptorelin LA in hysteroscopic metroplastic.
Septate uterus is the intracavitary pathology which is most associated with infertility and/or preterm labor; therefore, it is primary indication for hysteroscopic metroplasty. By the introductio of the resectoscope in gynaecological endoscopy the surgical technique has been revolutioned. GnRHa therapy before surgery has showed some advantages related to surgical results, surgery time, intraoperative bleeding and endometrial detachment, and amount of fluids used for uterine cavity distention. The treatment before hysteroscopic metroplasty for partial septus has not influenced positive results, while for uterine septus that reached the inferior third of the cavity or moreover, it provided better condition for this procedure.
Tantini
C
C
Institute of Gynaecology and Obstetrics, University of Florence, Italy.
Tiso
E
E
Ayub
A V
AV
Vizioli
C B
CB
D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D015907:Hysteroscopy / Q000379:methods*; D011300:Preoperative Care; D013997:Time Factors; D017329:Triptorelin Pamoate / Q000627:therapeutic use*; D014591:Uterine Diseases / Q000601:surgery; D014592:Uterine Hemorrhage / Q000517:prevention & control; D014599:Uterus / Q000002:abnormalities / Q000601:surgery*
D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone